Related Experiment Videos
Sequelae of acute bacterial meningitis in children treated for seven days
Insights
Seven days of intravenous antibiotics effectively treated bacterial meningitis in children, with 80% experiencing no long-term effects. This duration is adequate, comparable to longer treatment regimens.
Area of Science:
- Pediatrics
- Infectious Diseases
- Neurology
Background:
- Bacterial meningitis is a serious infection in children.
- Treatment duration for bacterial meningitis has been debated.
- Assessing long-term outcomes is crucial for treatment guidelines.
Purpose of the Study:
- To evaluate the sequelae of bacterial meningitis in children treated with a seven-day antibiotic course.
- To compare outcomes with previously reported longer treatment durations.
- To determine the adequacy of seven-day intravenous antibiotic therapy.
Main Methods:
- Prospective assessment of 235 children treated for bacterial meningitis between 1979 and 1983.
- Patients received ampicillin or chloramphenicol for seven days.
- Neurologic, psychometric, audiologic, and ophthalmologic assessments were performed on survivors for at least one year.
Main Results:
- The mortality rate was 6.4%, with no relapses.
- Of 220 survivors, 136 (80%) had no detectable sequelae.
- 20% of survivors experienced mild to severe handicaps, including sensorineural hearing loss (12.9%) and developmental delay (5.3%).
- Sequelae frequency varied by pathogen: highest with Streptococcus pneumoniae (57%) and lowest with Neisseria meningitidis (0%).
Conclusions:
- Seven days of intravenous antibiotic therapy is adequate for treating bacterial meningitis in children.
- The observed sequelae rates are similar to those reported for 10-14 day treatments.
- Treatment duration can be optimized without compromising patient outcomes.
Abstract:
The sequelae of acute bacterial meningitis in children who were treated with ampicillin or chloramphenicol for seven days during the period January 1979 to June 1983 were assessed prospectively. The 235 patients (117 boys and 118 girls) ranged in age from four days to 18 years (mean 26.4 months). Haemophilus influenzae type b was isolated in 70% of patients, Streptococcus pneumoniae in 20%, and Neisseria meningitidis in 10%. The mortality rate was 6.4%. No relapses occurred. Of the 220 survivors, 171 had neurologic psychometric, audiologic, and ophthalmologic assessments performed for a minimum of 1 year following their illness. One hundred thirty-six (80%) children had no detectable sequelae; 20% had mild to severe handicaps. The frequency of sequelae was greatest among children with S pneumoniae meningitis (57%) and least among children with N meningitidis (0%). The sequelae observed included: sensorineural hearing loss (12.9%), developmental delay (5.3%), speech defect (4.7%), motor defect (3.0%), hydrocephalus (1.7%), and seizure disorder (1%). The frequency of observed sequelae among these patients is similar to that previously reported in children treated for ten to 14 days. Our findings indicate that seven days of intravenous antibiotic therapy is adequate for the treatment of bacterial meningitis in children.